Loading…
logo
Celrixafor 24 mg Injection
Celrixafor 24 mg Injection
Prescription Required
Prescription Required

Celrixafor 24 mg Injection | 1.2 ml in 1 Vial

30400.00
You Save ₹ 25412.67
(Inclusive of all taxes)
discount
46% OFF
wishlist
Celon Laboratories Pvt Ltd
Plerixafor 24 mg
wishlist

Introduction of Celrixafor Injection

Celrixafor 24 mg Injection is an immunostimulant used in cancer patients, It mobilizes hematopoietic stem cells into blood stream. The chemical formula of this molecule is C28H54N8. It is also known as a Hematopoietic stem cell mobilized. Celrixafor 24 mg Injection causes blood cells to move from the bone marrow towards blood so they can be extracted for transplant


Uses of Celrixafor Injection

  • Non Hodgkin's lymphoma
  • Multiple Myeloma


Benefits of Celrixafor Injection

Celrixafor 24 mg Injection is used as a peripheral blood stem cell mobilization, which is a very useful source of hematopoietic stem cells for transplantation.


Side Effects of Celrixafor Injection

  • Burning
  • Crawling
  • Itching
  • Numbness
  • Vomiting
  • Headache


Most Common Side Effects of Celrixafor Injection

  • Constipation
  • Nausea
  • Dry mouth
  • Numbness
  • Stomach upset
  • Bloating
  • Lethargic
  • Muscle pain
  • Profuse perspiration
  • Rashes
  • Irritation


Common Side Effects of Celrixafor Injection

  • Bleeding
  • Unusual weakness
  • Severe epigastric pain
  • Joint pain
  • Dizziness


How to Use Celrixafor Injection?

Celrixafor 24 mg Injection is available as an injectable form that must be administered under the skin ( subcutaneously) as directed by your doctor under medical supervision only. Celrixafor 24 mg Injection is usually given 11 hours prior to blood filtering procedure. Dosage and frequency will be decided by your doctor as per your medical condition and weight and certain other factors.


How Celrixafor Injection Works?

Celrixafor 24 mg Injection is an inhibitor of the CXCR4 chemokine receptor and blocks the binding of its cognate ligand, SDF- 1 alfa. Once in the marrow, stem cell CXCR 4 can act to help anchor stem cells to the marrow matrix either directly via SDF -1 alfa or through the induction of other adhesion molecules. Treatment with plerixafor results in leukocytosis and elevations in circulating hematopoietic progenitor cells.

INDIA’S LARGEST SPECIALITY MEDICINES PLATFORM
Genuine Medicines

Genuine Medicines

Fast Delivery

Fast Delivery

Secure Payment

Secure Payment

Best prices & offers

Best prices & offers